Myriad Genetics Overview
Myriad Genetics Target Price
Analysts' 12-month price predictions for MYGN.
Get informed when a big investor buys or sells
+ FollowShare Price
$5.99
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-02-24 | UBSLu Li | $6 |  0.2% upside |  |
| 2025-11-04 | UBSLu Li | $8 | 33.6% upside | |
| 2025-05-07 | Craig-HallumBill Bonello | $18 | 200.5% upside | |
| 2025-05-07 | UBSLu Li | $7 | 16.9% upside | |
| 2025-05-07 | Wells FargoBrandon Couillard | $6 | 0.2% upside | |
| 2025-03-12 | Piper Sandler | $12.5 | 108.7% upside | |
| 2025-03-04 | Piper Sandler | $11.5 | 92% upside | |
| 2024-12-09 | Leerink PartnersPuneet Souda | $21 | 250.6% upside | |
| 2024-10-14 | ScotiabankSung Ji Nam | $34 | 467.6% upside | |
| 2024-09-19 | Morgan StanleyTejas Savant | $32 | 434.2% upside | |
| 2024-08-27 | Wells FargoBrandon Couillard | $35 | 484.3% upside | |
| 2024-08-07 | GuggenheimSubbu Nambi | $29 | 384.1% upside | |
| 2024-06-26 | ScotiabankSung Ji Nam | $29 | 384.1% upside | |
| 2024-05-13 | Piper SandlerJon Peterson | $28 | 367.4% upside | |
| 2023-12-21 | Piper SandlerDavid Westenberg | $23 | 284% upside | |
| 2022-10-05 | StephensMason Carrico | $22 | 267.3% upside | |
| 2022-04-19 | Goldman Sachs | $23 | 284% upside | |